Entrada Therapeutics logo

Entrada Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States201-500 Employees

Entrada Therapeutics is a Boston-based biotechnology company focused on developing genetic medicines capable of engaging intracellular targets that have historically been difficult to reach. Through proprietary, modular approaches, it is assembling a development portfolio aimed at neuromuscular and inherited retinal diseases, among other conditions. The firm’s lead programs include strategies to address Duchenne muscular dystrophy by exon skipping, reflecting its focus on intracellular genetic modulation.
Based in Boston, Massachusetts, the company operates as a clinical-stage biopharmaceutical firm addressing unmet needs in genetic diseases with limited treatment options. In 2026, Entrada announced progress on VX-670, a clinical-stage program for myotonic dystrophy type 1 that is being developed through a partnership.

Find Entrada Therapeutics employees' phone numbers or email addresses

Entrada Therapeutics Global Highlights

Location
Employees

North America
225

Minus sign iconPlus sign icon
  • United States Of America
    225

Europe
3

Minus sign iconPlus sign icon
  • Italy
    1
  • Spain
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1

Africa
1

Minus sign iconPlus sign icon
  • Algeria
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Entrada Therapeutics's Leadership

  • Managing Broker And Owner at Entrada Therapeutics
    C. P.
    Managing Broker And Owner
  • Sr Director Of Regulatory Affairs at Entrada Therapeutics
    X. W.
    Sr Director Of Regulatory Affairs
  • Senior Manager, Clinical Supply Chain at Entrada Therapeutics
    M. B.
    Senior Manager, Clinical Supply Chain
  • Manager, Qa Gmp at Entrada Therapeutics
    K. C.
    Manager, Qa Gmp
  • Senior Scientist at Entrada Therapeutics
    G. W.
    Senior Scientist
  • Senior Research Associate at Entrada Therapeutics
    S. A.
    Senior Research Associate
  • Scientist Ii at Entrada Therapeutics
    T. D.
    Scientist Ii
  • Clinical Development Consultant at Entrada Therapeutics
    N. W.
    Clinical Development Consultant

Entrada Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Human Resources
  • Analytics
  • Biotechnology
  • Other
  • Finance
  • Recruiting
  • Engineering
  • Business
  • Legal
  • Accounting
  • Administrative

Contact profiles from Entrada Therapeutics

Name
Title
Contact
Location
Last Update
  • Managing Broker And Owner at Entrada Therapeutics
    C. P.
    Managing Broker And Owner
    Oct 16, 2024
  • Sr Director Of Regulatory Affairs at Entrada Therapeutics
    X. W.
    Sr Director Of Regulatory Affairs
    Aug 04, 2026
  • Senior Manager, Clinical Supply Chain at Entrada Therapeutics
    M. B.
    Senior Manager, Clinical Supply Chain
    Apr 16, 2026
  • Manager, Qa Gmp at Entrada Therapeutics
    K. C.
    Manager, Qa Gmp
    Aug 04, 2026
  • Senior Scientist at Entrada Therapeutics
    G. W.
    Senior Scientist
    Jun 22, 2026
  • Senior Research Associate at Entrada Therapeutics
    S. A.
    Senior Research Associate
    May 12, 2025
  • Scientist Ii at Entrada Therapeutics
    T. D.
    Scientist Ii
    Sep 12, 2023
  • Clinical Development Consultant at Entrada Therapeutics
    N. W.
    Clinical Development Consultant
    Australia, Victoria
    Aug 04, 2026
  • Recruiting Specialist at Entrada Therapeutics
    A. S.
    Recruiting Specialist
    Oct 23, 2024
  • Executive Assistant at Entrada Therapeutics
    J. W.
    Executive Assistant
    May 08, 2024

Frequently Asked Questions

What is Entrada Therapeutics known for?

Minus sign iconPlus sign icon
Entrada Therapeutics was founded in 2016 and operates in the Biotechnology Research industry. Explore Entrada Therapeutics's company overview page for more information.

What is Entrada Therapeutics's most common email format?

Minus sign iconPlus sign icon
Entrada Therapeutics employees' email format typically follows the pattern of FLast@entradatx.com. Trying to find reliable and up-to-date employee contact data? Find more Entrada Therapeutics email formats with LeadIQ.

How many employees does Entrada Therapeutics have currently?

Minus sign iconPlus sign icon
Entrada Therapeutics has approximately 205 employees as of August 2026. These team members are located across 4 continents, including North America, Europe and Africa.

Who are Entrada Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Entrada Therapeutics's key employees include:

  • Managing Broker And Owner: C. P.
  • Sr Director Of Regulatory Affairs: X. W.
  • Senior Manager, Clinical Supply Chain: M. B.
  • Manager, Qa Gmp: K. C.
  • Senior Scientist: G. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.